Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Abaxis, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Canaccord Genuity Cuts Price Target on Abaxis (ABAX) Following Investor Meetings
-
Canaccord Genuity Highlighted 6 Potential E&P 'Comeback Kids' for 2016
-
Canaccord Ups Abaxis (ABAX) PT on Major Deal Win
-
Abaxis, Inc. to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostic Forum
-
Canaccord Genuity Cuts Price Target on Abaxis (ABAX) Following New Veterinary Survey
-
Abaxis, Inc. to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Notable Analyst Rating Changes 7/24: (UAL) (SCTY) (DIS) Upgraded; (IAG) (CF) (ABAX) Downgraded
-
Canaccord Genuity Downgrades Abaxis Inc. (ABAX) to Hold
-
Canaccord Genuity Cuts Price Target on Abaxis (ABAX) Following Veterinarian Survey
-
Abaxis (ABAX) PT Lifted to $72 at Canaccord Genuity
-
Canaccord Genuity Upgrades Abaxis Inc. (ABAX) to Buy
-
UPDATE: Canaccord Genuity Starts IDEXX Laboratories (IDXX) at Hold; Leading Provider, But FTC Dragging Feet
-
Canaccord Genuity Raises Price Target on Abaxis Inc. (ABAX); Vet Performing Well
-
Canaccord Genuity Q1 Preview on Abaxis Inc. (ABAX): Too Far, Too Fast
